PMID- 33569417 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220420 IS - 2305-5839 (Print) IS - 2305-5847 (Electronic) IS - 2305-5839 (Linking) VI - 9 IP - 2 DP - 2021 Jan TI - Gender differences of relationship between serum lipid indices and type 2 diabetes mellitus: a cross-sectional survey in Chinese elderly adults. PG - 115 LID - 10.21037/atm-20-2478 [doi] LID - 115 AB - BACKGROUND: To investigate the gender differences of the relationships between clinical serum lipid indices and type 2 diabetes mellitus (T2DM) in Chinese elderly adults. METHODS: Between 2014 and 2016, participants selected from three communities in an urban district of Shanghai were measured for serum lipid indices of low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), total cholesterol (TC), and triglyceride (TG). Age and multivariate adjusted logistic regression models were utilized to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) of serum lipid indices on T2DM prevalence. RESULTS: In total, 4,023 male and 3,862 female participants were included in this study, with the T2DM prevalence proportions of 13.03% and 11.73%, respectively. In association analysis, the serum levels of LDL-c, HDL-c, TC were significant between non-T2DM individuals and T2DM patients in men, but the HDL-c and TG in women. LDL-c/HDL-c, TG/HDL-c, and TC/HDL-c ratios were associated with the T2DM prevalence only in women. In the multivariate analysis, a higher serum LDL-c level was positively associated with a reduced risk of T2DM prevalence in men with OR (95% CI) of 0.57 (0.39-0.85) (P=0.006). Higher ratios of LDL-c/HDL-c, TG/HDL-c, and TC/HDL-c were all more likely associated with the decreased risks of T2DM prevalence with the ORs ranging from 0.45 to 0.62 in men (all P<0.05), but not in women. CONCLUSIONS: High LDL-c concentration was significantly associated with a lower T2DM prevalence in men. A gender difference of the associations between the lipid ratios and T2DM prevalence was observed for LDL-c/HDL-c and TC/HDL-c ratios, which might be validated in female T2DM prevalence in the future. CI - 2021 Annals of Translational Medicine. All rights reserved. FAU - Ji, Xiao-Wei AU - Ji XW AD - School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. AD - State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Feng, Guo-Shan AU - Feng GS AD - School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. AD - State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Li, Hong-Lan AU - Li HL AD - State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Fang, Jie AU - Fang J AD - State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Wang, Jing AU - Wang J AD - State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Shen, Qiu-Ming AU - Shen QM AD - State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Han, Li-Hua AU - Han LH AD - State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Liu, Da-Ke AU - Liu DK AD - State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Xiang, Yong-Bing AU - Xiang YB AD - School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. AD - State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. LA - eng PT - Journal Article PL - China TA - Ann Transl Med JT - Annals of translational medicine JID - 101617978 PMC - PMC7867915 OTO - NOTNLM OT - Serum lipid indices OT - cross-sectional study OT - gender difference OT - type 2 diabetes mellitus (T2DM) COIS- Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-2478). Dr. YBX reports grants from Research Grant from the State Key Laboratory of Oncogenes and Related Genes (#91-1708), during the conduct of the study. The other authors have no conflicts of interest to declare. EDAT- 2021/02/12 06:00 MHDA- 2021/02/12 06:01 PMCR- 2021/01/01 CRDT- 2021/02/11 05:55 PHST- 2021/02/11 05:55 [entrez] PHST- 2021/02/12 06:00 [pubmed] PHST- 2021/02/12 06:01 [medline] PHST- 2021/01/01 00:00 [pmc-release] AID - atm-09-02-115 [pii] AID - 10.21037/atm-20-2478 [doi] PST - ppublish SO - Ann Transl Med. 2021 Jan;9(2):115. doi: 10.21037/atm-20-2478.